McKesson Corporation
McKesson Corporation Announces Closing of $2 Billion Notes Offering
Summary
On May 20, 2025, McKesson Corporation closed an offering of $2 billion aggregate principal amount of its 2030, 2032, and 2035 Notes. The proceeds will fund the acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC. The 2030 Notes bear interest at 4.650%, the 2032 Notes at 4.950%, and the 2035 Notes at 5.250%. The notes are unsecured and unsubordinated obligations of the Company.
Profitelligence Alerts
Get alerts for MCK
Be first to know when McKesson Corporation files with the SEC.
Filing Categories
Exhibits (3)
Advertisement
About McKesson Corporation
McKesson Corporation is a leading healthcare services and information technology company. It plays a crucial role in the distribution of pharmaceuticals and medical products. The primary function of McKesson is to ensure the efficient delivery of healthcare products to pharmacies, hospitals, and other medical facilities, ensuring that millions of patients have access to the medications they need. It also provides specialized software and automated solutions that enhance operational efficiency in healthcare sectors. McKesson significantly impacts the pharmaceutical and healthcare industries by offering solutions that streamline supply chains and improve patient care. Its services encompass wholesale drug distribution, healthcare IT systems, and pharmacy management. With operations that extend globally, McKesson is integral to maintaining the integrity and reliability of healthcare supply networks. By handling a substantial portion of the pharmaceutical distribution in North America, McKesson Corporation has a vital market presence, emphasizing its importance in shaping healthcare logistics and innovation. Its efforts contribute to advancing healthcare delivery and responding to the evolving demands of the medical industry.
Official SEC Documents
Advertisement